I have been monitoring humanwell Healthcare and one of their primary portfolios is in the CNS arena. just so happens we have 2 waiting fda approval and then of course the new BOD tied to the previous buyout of epic/humanwell.
No problem ted. Our time will come very soon. 2 other key points without delving too much into the technical charting aspect.
Short interest is down about 74% and the accumulation distribution line is mountainous, just to accompany all the other recent and pending events and terrific charts on multiple time frames.